Results 31 to 40 of about 1,253,674 (265)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)

open access: yesJournal of Fungi, 2021
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe fungal infection complicating critically ill COVID-19 patients.
S. Feys   +6 more
semanticscholar   +1 more source

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis

open access: yesEmerging Infectious Diseases, 2021
We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease–associated pulmonary aspergillosis (CAPA). We found 10%–15% CAPA incidence among 823 patients in 2 cohorts.
N. Janssen   +31 more
semanticscholar   +1 more source

Prevalence of pulmonary aspergillosis among chronic obstructive pulmonary disease patients presented with acute exacerbation

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2019
Introduction Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a major event through the life of all chronic obstructive pulmonary disease (COPD) patients.
Mostafa Shawki, H.M. Abdel-Hamid
doaj   +1 more source

COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients

open access: yesClinical Infectious Diseases, 2021
Background COVID-19 associated pulmonary aspergillosis (CAPA) occurs in critically ill COVID-19 patients. Risks and outcomes remain poorly understood.
N. Permpalung   +8 more
semanticscholar   +1 more source

Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis

open access: yesMycoses (Berlin), 2021
COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported worldwide. However, basic epidemiological characteristics have not been well established.
H. Mitaka   +3 more
semanticscholar   +1 more source

Pulmonary sequestration and aspergillosis [PDF]

open access: yesEuropean Journal of Cardio-Thoracic Surgery, 2005
Pulmonary sequestration (PS) is an uncommon congenital disease. Symptoms when present are usually secondary to pyogenic infection. Our objective was to draw attention on superimposed fungal infection.During the last 20 years, we operated upon 19 intralobar PS.
Pascal, Berna   +5 more
openaire   +2 more sources

Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC.

open access: yesClinical Infectious Diseases, 2021
BACKGROUND Clinical imaging in suspected invasive fungal disease (IFD) has a significant role in early detection of disease and helps direct further testing and treatment.
B. Alexander   +6 more
semanticscholar   +1 more source

A Case Series of Chronic Necrotizing Pulmonary Aspergillosis and a New Proposal [PDF]

open access: yes, 2013
Chronic necrotizing pulmonary aspergillosis (CNPA) is an indolent, cavitating process in the lungs resulting from invasion of lung tissue by Aspergillus spp.
Kakeya, Hiroshi   +12 more
core   +1 more source

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

open access: yesJournal of Fungi, 2020
Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated ...
A. Arastehfar   +9 more
semanticscholar   +1 more source

Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis

open access: yesInfection, 2021
Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19 patients, termed COVID-19-associate pulmonary aspergillosis (CAPA).
W. Chong, B. Saha, Kristoffer P. Neu
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy